A new study jointly conducted by digital chronic care management tool Omada and Evidation Health found that patients using Omada’s diabetes management program reduced their A1c level and average of ...
In the phase 3 study, QWINT-1, efsitora was administered via four fixed doses once weekly in a single-use autoinjector in people with type 2 diabetes using basal insulin for the first time In a second ...
Trial participants taking the highest dose of tirzepatide (15 mg) achieved an A1C reduction of 2.46 percent and weight loss of 12.4 kg (27.3 lb., 13.1 percent), double the weight reduction compared to ...
Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week dosing regimen for people living with type 2 diabetes Efsitora was equally safe and effective among adults naïve to ...
Detailed results were published in The Lancet and simultaneously presented at the European Association for the Study of Diabetes (EASD) Annual Meeting 2024 In the trial, efsitora met the primary ...
A higher volume of exercise training may improve glycemic control more in individuals with type 2 diabetes (T2D) compared with individuals who exercise less frequently, according to a stud in Medicine ...
A reduction in glycated hemoglobin (A1C) may result in improved perinatal and maternal outcomes among women with prepregnancy diabetes, according to results of a cohort study published in JAMA Network ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Kelly Burch Every time Kelly publishes a story, you’ll get an alert straight to your inbox!
Blood sugar management is a central component of diabetes care. One of the most crucial tools for managing diabetes is the A1C test, which provides valuable insights into a person’s blood sugar levels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback